BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2920312)

  • 1. Biologic and structural evaluation of 80 surgically excised human umbilical vein grafts.
    Julien S; Gill F; Guidoin R; Guzman R; Charara J; Roy PE; Marois M; Laroche G; Batt M; Roy P
    Can J Surg; 1989 Mar; 32(2):101-7. PubMed ID: 2920312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human umbilical vein grafts as infrainguinal bypasses: long-term clinical follow-up and pathological investigation of explanted grafts.
    Batt M; Gagliardi JM; Avril G; Guzman R; Guidoin R; Hassen-Khodja R; Marois M; Le Bas P
    Clin Invest Med; 1990 Aug; 13(4):155-64. PubMed ID: 2208831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infrapopliteal composite bypass with autologous vein and second generation glutaraldehyde stabilized human umbilical vein (HUV) for critical lower limb ischaemia.
    Neufang A; Espinola-Klein C; Dorweiler B; Savvidis S; Schmiedt W; Vahl CF
    Eur J Vasc Endovasc Surg; 2007 Nov; 34(5):583-9. PubMed ID: 17574877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic features of surgically excised human umbilical vein grafts.
    Guidoin R; Gagnon Y; Roy PE; Marois M; Johnston KW; Batt M
    J Vasc Surg; 1986 Jan; 3(1):146-54. PubMed ID: 3941479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of conduits for leg revascularization.
    Weisel RD; Johnston KW; Baird RJ; Drezner AD; Oates TK; Lipton IH
    Surgery; 1981 Jan; 89(1):8-15. PubMed ID: 7466615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of graft type on patency of infrainguinal arterial bypass grafts.
    Neale ML; Graham JC; Lane RJ; Cheung DS; Appleberg M
    J Am Coll Surg; 1994 Feb; 178(2):155-63. PubMed ID: 8173726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of autologous graft and human umbilical vein graft in femorocrural bypasses--a preliminary report.
    Rondhuis JJ; van Iersel JG; Taks AC
    Neth J Surg; 1985 Apr; 37(2):50-3. PubMed ID: 4000519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Grafting of autogenous jugular vein and glutaraldehyde-stabilized human umbilical vein in dogs].
    Xu K; Chen W
    Zhonghua Yi Xue Za Zhi; 1993 Jul; 73(7):413-5, 447. PubMed ID: 8293344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of human umbilical vein grafts.
    Harris JP; Farey I; Stephen MS; Sheil AG; May J
    Surgery; 1984 Jul; 96(1):23-8. PubMed ID: 6740493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-greater saphenous vein grafting for infrageniculate bypass.
    Alexander J; Gutierrez C; Katz S
    Am Surg; 2002 Jul; 68(7):611-4. PubMed ID: 12132743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential femorodistal composite bypass with second generation glutaraldehyde stabilized human umbilical vein (HUV).
    Neufang A; Espinola-Klein C; Dorweiler B; Reinstadler J; Pitton M; Savvidis S; Fischer R; Vahl C; Schmiedt W
    Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):176-83. PubMed ID: 15950502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTFE-vein composite grafts for critical limb ischaemia: a valuable alternative to all-autogenous infrageniculate reconstructions.
    Bastounis E; Georgopoulos S; Maltezos C; Alexiou D; Chiotopoulos D; Bramis J
    Eur J Vasc Endovasc Surg; 1999 Aug; 18(2):127-32. PubMed ID: 10426969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal outcome after tibial arterial bypass.
    Shah DM; Paty PS; Leather RP; Chang BB; Darling RC; Feustel PJ
    Surg Gynecol Obstet; 1993 Sep; 177(3):283-7. PubMed ID: 8356500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and late comparison of umbilical vein and PTFE grafts in control and piroxicam-treated dogs.
    Solis E; Hollier LH; Plate G; Dewanjee MK; Kaye MP
    Int Angiol; 1986; 5(2):73-8. PubMed ID: 3746016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arm vein reconstruction for limb salvage: long-term outcome.
    Tisi PV; Crow AJ; Shearman CP
    Ann R Coll Surg Engl; 1996 Nov; 78(6):497-500. PubMed ID: 8943631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective use of modified human umbilical vein as an arterial substitute in the lower extremity.
    Buth J; Cohen RF; Adhin SK
    Surg Gynecol Obstet; 1983 Dec; 157(6):523-9. PubMed ID: 6648771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibrous hyperplasia in femoro-popliteal bypasses using treated human umbilical veins].
    Guidoin R; Roy PE; Langeron P; Puppinck P; Paynter R; Gosselin C
    J Mal Vasc; 1987; 12(4):329-33. PubMed ID: 3694057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Below knee femoropopliteal bypass in severe ischaemia: results using EXS Dacron and human umbilical vein.
    Clifford PC; Gazzard V; Lawrance RJ; Clyne CA; Webster JH
    Ann R Coll Surg Engl; 1986 Nov; 68(6):319-22. PubMed ID: 2949686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human umbilical vein versus heparin-bonded polyester for femoro-popliteal bypass: 5-year results of a prospective randomized multicentre trial.
    Scharn DM; Dirven M; Barendregt WB; Boll AP; Roelofs D; van der Vliet JA
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):61-7. PubMed ID: 17936036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological vascular grafts.
    Wengerter K; Dardik H
    Semin Vasc Surg; 1999 Mar; 12(1):46-51. PubMed ID: 10100385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.